J Appl Biomed 12:191-192, 2014 | DOI: 10.1016/j.jab.2014.09.002

Oxime treatment for organophosphorus compound exposure: Getting it (into the brain) might not be that good for you, after all

Georg A. Petroianu
Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA

Keywords: Brain; Hydrophilicity; Oxime; Wars; Terrorism; Toxicity

Published: November 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Petroianu GA. Oxime treatment for organophosphorus compound exposure: Getting it (into the brain) might not be that good for you, after all. J Appl Biomed. 2014;12(4):191-192. doi: 10.1016/j.jab.2014.09.002.
Download citation

References

  1. Becker, G., Kawan, A., Gutzeit, D., Worek, F., Szinicz, L., 2007. Direct reaction of oximes with crotylsarin, cyclosarin, or VX in vitro. Arch. Toxicol. 81, 415-420. Go to original source... Go to PubMed...
  2. Bodor, N., Shek, E., Higuchi, T., 1976. Improved delivery through biological membranes. 1. Synthesis and properties of 1methyl-1,6-dihydropyridine-2-carbaldoxime, a pro-drug of N-methylpyridinium-2-carbaldoxime chloride. J. Med. Chem. 19, 102-107. Go to original source... Go to PubMed...
  3. Buckley, N.A., Eddleston, M., Li, Y., Bevan, M., Robertson, J., 2011. Oximes for acute organophosphate pesticide poisoning. Cochrane Database Syst. Rev. CD005085.
  4. Kiderlen, D., Eyer, P., Worek, F., 2005. Formation and disposition of diethylphosphoryl-obidoxime, a potent anticholinesterase that is hydrolyzed by human paraoxonase (PON1). Biochem. Pharmacol. 69, 1853-1867. Go to original source... Go to PubMed...
  5. Lorke, D.E., Petroianu, G.A., 2009. Minireview: does in-vitro testing of oximes help predict their in-vivo action after paraoxon exposure? J. Appl. Toxicol. 29, 459-469. Go to original source... Go to PubMed...
  6. Lorke, D.E., Hasan, M.Y., Nurulain, S.M., Sheen, R., Kuča, K., Petroianu, G.A., 2007. Entry of two new asymmetric bispyridinium oximes (K-27 and K-48) into the rat brain: comparison with obidoxime. J. Appl. Toxicol. 27, 482-490. Go to original source... Go to PubMed...
  7. Lorke, D.E., Kalasz, H., Petroianu, G.A., Tekes, K., 2008. Entry of oximes into the brain: a review. Curr. Med. Chem. 15, 743-753. Go to original source... Go to PubMed...
  8. Petroianu, G., 2005. Organophosphate poisoning: the lesserknown face of a toxidrome. Eur. J. Emerg. Med. 12, 102-103. Go to original source... Go to PubMed...
  9. Petroianu, G., Toomes, L.M., Petroianu, A., Bergler, W., Rüfer, R., 1998. Control of blood pressure, heart rate and haematocrit during high-dose intravenous paraoxon exposure in mini pigs. J. Appl. Toxicol. 18, 293-298. Go to original source... Go to PubMed...
  10. Petroianu, G.A., Lorke, D.E., Hasan, M.Y., Adem, A., Sheen, R., Nurulain, S.M., Kalász, H., 2007. Paraoxon has only a minimal effect on pralidoxime brain concentration in rats. J. Appl. Toxicol. 27, 350-357. Go to original source... Go to PubMed...
  11. Petroianu, G., Athauda, G., Darvas, F., Kalász, H., Lorke, D., 2014. K-oxime (k-27): phosphylation-induced changes In log P. Mil. Med. Sci. Lett. 83, 1-7. Go to original source...
  12. Shek, E., Higuchi, T., Bodor, N., 1976. Improved delivery through biological membranes. 2. Distribution, excretion, and metabolism of N-methyl-1,6-dihydropyridine-2carbaldoxime hydrochloride, a pro-drug of Nmethylpyridinium-2-carbaldoxime chloride. J. Med. Chem. 19, 108-112. Go to original source... Go to PubMed...
  13. Voicu, V.A., Bajgar, J., Medvedovici, A., Radulescu, F.S., Miron, D. S., 2010. Pharmacokinetics and pharmacodynamics of some oximes and associated therapeutic consequences: a critical review. J. Appl. Toxicol. 30, 719-729. Go to original source... Go to PubMed...